Description
Rôles et compétences
Rôles et compétences
- A Systematic Review of the Characteristics and Outcomes of Cancer Nurse Practitioner Roles in Australia.on 10 Décembre 2025
Seminars in Oncology Nursing; 12/01/2025The Australian cancer health care system remains slow in realizing the benefit of nurse practitioner (NP) roles. The aim of this systematic review was to […]
Formation et apprentissage
- Symptom Management Guideline Implementation Among Nurses in Cancer-Specific Outpatient Settings: A Scoping Review of Barriers, Facilitators, and Implementation Strategies.on 10 Décembre 2025
Cancer Nursing; 01/01/2026Background: Oncology outpatients experience high levels of distressing cancer-related symptoms. Nurses can provide high-quality outpatient cancer symptom management […]
Spécialités cliniques
Oncologie médicale
- Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trialon 10 Décembre 2025
J Clin Oncol. 2025 Nov 25:JCO2501153. doi: 10.1200/JCO-25-01153. Online ahead of print.ABSTRACTPURPOSE: To evaluate the efficacy and safety of the bispecific human epidermal growth factor receptor 2 […]
Chirurgie oncologique
- Exploring the eHealth literacy and related influencing factors in patients after lung cancer surgery: A latent profile analysison 10 Décembre 2025
Asia Pac J Oncol Nurs. 2025 Nov 11;12:100818. doi: 10.1016/j.apjon.2025.100818. eCollection 2025 Dec.ABSTRACTOBJECTIVE: This study aimed to clarify the subtypes of electronic health literacy among […]
Radio-oncologie
- Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)on 5 Décembre 2025
Oncol Rep. 2026 Feb;55(2):31. doi: 10.3892/or.2025.9036. Epub 2025 Dec 5.ABSTRACTAlternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers […]
Traitements et interventions
Traitements non-pharmacologiques
- Trends in Opioids and Non-Pharmacologic Pain Management among U.S. Cancer Survivors, 2011-2020on 10 Décembre 2025
Arch Phys Med Rehabil. 2025 Dec 2:S0003-9993(25)01068-8. doi: 10.1016/j.apmr.2025.11.019. Online ahead of print.ABSTRACTOBJECTIVE: It is unknown how the U.S. opioid epidemic influenced the […]
Approches complémentaires
- Beyond Distraction: Music Therapy for Chronic Pain Management in People with Advanced Cancer.on 10 Décembre 2025
Integrative Cancer Therapies; 11/26/2025Objective: Effective, non-pharmacological approaches to pain management for people with advanced cancer that can enhance quality of life while minimizing […]
Réadaptation, physiothérapie et ergothérapie
- Telerehabilitation in Postoperative Breast Cancer Care: Systematic Review and Meta-Analysison 10 Décembre 2025
JMIR Rehabil Assist Technol. 2025 Dec 9;12:e77161. doi: 10.2196/77161.ABSTRACTBACKGROUND: Postoperative rehabilitation is essential to improve quality of life (QoL), pain control, and upper limb […]
Éducation aux patients et littératie en santé
- Health Literacy, Self-Management and Patient-Reported Outcomes in Prostate Cancer Survivors: A Mixed Methods Systematic Reviewon 5 Décembre 2025
Semin Oncol Nurs. 2025 Nov 28:152056. doi: 10.1016/j.soncn.2025.152056. Online ahead of print.ABSTRACTOBJECTIVES: To systematically review the literature to identify the influence of health literacy […]
Organisation des soins
Organisation et unités de soins
- What are the Key Components of an Advanced Nurse Practitioner (ANP) Led High-Risk Family History Breast Clinic? A Scoping Reviewon 3 novembre 2025
Semin Oncol Nurs. 2025 Sep 25:152018. doi: 10.1016/j.soncn.2025.152018. Online ahead of print.ABSTRACTOBJECTIVES: To identify what is known in the existing literature about the key components of an […]
Trajectoires de soins
- Brief Post-Surgical Stress Management Intervention Effects on Positive Psychological Well-Being and Self-Efficacy in Women Being Treated With Adjuvant Endocrine Therapy for Hormone-Receptor Positive Breast Canceron 11 septembre 2025
Psychooncology. 2025 Aug;34(8):e70267. doi: 10.1002/pon.70267.ABSTRACTBACKGROUND: Women prescribed adjuvant endocrine therapy (AET) for nonmetastatic breast cancer may experience a decline in […]
Performance et indicateurs
- The Cost-Effectiveness of Nursing Interventions in Cancer Care: Systematic Review.on 11 septembre 2025
Seminars in Oncology Nursing; 08/01/2025This study aimed to comprehensively examine the studies evaluating the cost impact of nursing intervention in cancer care. PubMed, Scopus, Web of Science, […]
Amélioration de la qualité et meilleures pratiques
- What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Reviewon 10 Décembre 2025
JCO Oncol Pract. 2025 Dec 2:OP2500586. doi: 10.1200/OP-25-00586. Online ahead of print.ABSTRACTPURPOSE: Second opinions in oncology may optimize treatment plans, resulting in improved outcomes such […]
Innovation
- Limitations in Artificial Intelligence–Driven Patient-Centered Cancer Nursing Research.on 10 Décembre 2025
JAMA Oncology; 11/01/2025(AN 189492005); ISSN: 23742437CINAHL Complete
Expériences des patients
Expériences des patients
- Mapping the experiences of adult cancer patients receiving chimeric antigen receptor T-cell (CAR-T) therapy: A scoping review protocolon 10 Décembre 2025
PLoS One. 2025 Dec 5;20(12):e0338210. doi: 10.1371/journal.pone.0338210. eCollection 2025.ABSTRACTINTRODUCTION: Chimeric antigen receptor T-cell (CAR T) therapy is an advancement in cancer […]
Participation des patients
- Adherence, Compliance Rates, and Response to Training Among Patients Awaiting Colorectal Cancer Surgery: A Secondary Analysis From the PREHAB Multicentre Trialon 10 Décembre 2025
Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18668-w. Online ahead of print.ABSTRACTBACKGROUND: Compliance with training protocol is essential to achieve physiologic improvements associated […]
Résultats rapportés par les patients
- Aesthetic Flat Closure Following Mastectomy: A Systematic Review of Techniques, Outcomes, and Patient Perspectiveson 10 Décembre 2025
Aesthetic Plast Surg. 2025 Dec 3. doi: 10.1007/s00266-025-05180-5. Online ahead of print.ABSTRACTBACKGROUND: Aesthetic flat closure (AFC) after mastectomy is increasingly chosen by patients who forgo […]
Survivance
- Investing in prostate cancer survivorship.on 10 Décembre 2025
Canadian Urological Association Journal; 12/01/2025The article focuses on the cost-effectiveness of the Prostate Cancer Patient Empowerment Program (PC-PEP), a survivorship intervention designed for […]
Publications d'associations professionnelles
Canadian Association of Nurses in Oncology (CANO/ACIO)
- Therapeutic breakthroughs in oncology: Enhancing treatment and managementon 11 septembre 2025
Can Oncol Nurs J. 2025 Jul 1;35(4):590-605. doi: 10.5737/23688076354590. eCollection 2025.ABSTRACTRecent advancements in oncology have significantly transformed cancer treatment and care management, offering new hope to patients worldwide. This literature review examines key therapeutic breakthroughs, including targeted therapies, immunotherapies, personalized medicine, and innovative drug delivery systems. These cutting-edge interventions have enhanced patient outcomes, improving survival rates and quality of life, but they have also introduced complexities in managing emerging side effects, care coordination, and resource allocation. This review discusses the implications of these therapies on patient care, the ethical considerations they entail, the management of side effects, and the pivotal role of oncology nurses in administering and managing these treatments. By exploring the current landscape and future directions of oncology therapies, including areas such as cancer vaccines and precision medicine, this article provides a comprehensive understanding of how these innovations are shaping the future of cancer care.PMID:40873601 | PMC:PMC12379890 | DOI:10.5737/23688076354590
Oncology Nursing Society (ONS)
- Interprofessional Collaboration in Cancer Care: A Perspective on Interventional Oncology Programson 10 Décembre 2025
Clin J Oncol Nurs. 2025 Nov 19;29(6):E34-E39. doi: 10.1188/25.CJON.S1.E34-E39.ABSTRACTBACKGROUND: An interprofessional approach to patient care contributes to quality outcomes, aligned goals of care, and communication among teams. Interventional oncology (IO) is an innovative specialty that may combine multiple disciplines and requires effective communication and a team-based approach to deliver high-quality care.OBJECTIVES: This article presents a leadership perspective on interprofessional collaboration in cancer care, specifically focusing on the importance of communication and a team-based approach for patient-centered care within IO programs.METHODS: The author conducted a search using the CINAHL® Plus database. Keywords such as interventional oncology, interventional oncology nursing, and interventional oncology programs and associated themes, including multidisciplinary collaboration and tumor boards, were used to identify evidence within the IO specialty.FINDINGS: Advancements in treatment provide patients with options to manage their disease among multiple disciplines. There is minimal to no evidence on IO programs and their impact on patient outcomes through interprofessional collaboration. Clinical IO care teams need to operate in an interprofessional framework to provide patient-centered care.PMID:41269738 | DOI:10.1188/25.CJON.S1.E34-E39
American Society of Clinical Oncology (ASCO)
- Large Language Models in Population Oncology: A Contemporary Review on the Use of Large Language Models to Support Data Collection, Aggregation, and Analysis in Cancer Care and Researchon 3 novembre 2025
JCO Clin Cancer Inform. 2025 Oct;9:e2500112. doi: 10.1200/CCI-25-00112. Epub 2025 Oct 24.ABSTRACTOver the past 5 years, large language models (LLMs) have emerged and continued to improve in their generative abilities and are now capable of generating human-understandable text and performing complex data analyses. As these models continue to improve in their capabilities, they are increasingly used to support population oncology, including clinical information extraction, cancer care education, and clinical decision support. This narrative review provides a high-level description of the use of LLMs in cancer with an overview of the current literature, along with research gaps. Despite increasing interest in using LLMs for cancer care, prevention, and research, applied methods in cancer still lag advancements published in the computer science literature. Therefore, we recommend that cancer-focused LLM research and applications better incorporate technical advancements and techniques found in the computer science literature. Additionally, standardized evaluation metrics and approaches need to be better studied and adopted in oncology, along with data governance and computational infrastructure to support state-of-the-art model integration and the use of real-world data. Finally, we describe the need for researchers to incorporate principles and frameworks from implementation and dissemination science to promote LLM-based tool adaptation, effectiveness, fit, and sustainability.PMID:41135040 | DOI:10.1200/CCI-25-00112
National Comprehensive Cancer Network (NCCN)
- NCCN Guidelines® Insights: Breast Cancer, Version 5.2025on 10 Décembre 2025
J Natl Compr Canc Netw. 2025 Nov;23(11):426-436. doi: 10.6004/jnccn.2025.0053.ABSTRACTThe treatment landscape of invasive early-stage and metastatic breast cancer is evolving constantly. These NCCN Guidelines Insights focus on recent updates included in the most recent version (version 5.2025) of the NCCN Guidelines for Breast Cancer specific to workup, locoregional therapy, surveillance, and systemic neoadjuvant/adjuvant therapy recommendations for invasive, nonmetastatic breast cancer.PMID:41213254 | DOI:10.6004/jnccn.2025.0053
European Society for Medical Oncology (ESMO)
- EU Cancer Mission and Partners Launch First Cancer Mission Forum for Rare Cancerson 10 Décembre 2025
The ESMO Rare Cancers Working Group (RCWG) is pleased to report significant progress in advancing coordinated action for rare cancers at European level
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


